Prof. Dr. Bazbek Davletov completed his Ph.D. in the lab of Nobel Prize winner Prof. Thomas Sudhof at the University of Texas Southwestern Medical Center, Dallas, USA. He has been a Program Leader at the MRC Laboratory of Molecular Biology at Cambridge since 1998, before becoming the Chair of Biomedical Science and a Professor at the University of Sheffield. Prof Davletov’s lab pursues research on neurological disorders including chronic neuropathic pain, with a focus on developing enhanced delivery methods. His work encompasses the study of the mechanisms of action of potent neurotoxins and the molecular mechanisms of neurotransmission; based on this research, his group is able to test and utilize potential therapeutic molecules, for example, SNAP25 and botulinum toxins, for the selective treatment of chronic pain.
Prof. Dr. Bazbek Davletov completed his Ph.D. in the lab of Nobel Prize winner Prof. Thomas Sudhof at the University of Texas Southwestern Medical Center, Dallas, USA. He has been a Program Leader at the MRC Laboratory of Molecular Biology at Cambridge since 1998, before becoming the Chair of Biomedical Science and a Professor at the University of Sheffield. Prof Davletov’s lab pursues research on neurological disorders including chronic neuropathic pain, with a focus on developing enhanced delivery methods. His work encompasses the study of the mechanisms of action of potent neurotoxins and the molecular mechanisms of neurotransmission; based on this research, his group is able to test and utilize potential therapeutic molecules, for example, SNAP25 and botulinum toxins, for the selective treatment of chronic pain.